电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

CCL2 抗体 (AA 24-96)

The 兔 多克隆 anti-CCL2 antibody (ABIN6719598) specifically detects CCL2 in WB 和 ELISA. The antibody is reactive with 小鼠 和 大鼠 samples.
产品编号 ABIN6719598
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for CCL2 抗体 (AA 24-96) (ABIN6719598)

抗原

See all CCL2 抗体
CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))

适用

  • 113
  • 61
  • 56
  • 24
  • 17
  • 16
  • 15
  • 9
  • 3
  • 3
  • 1
小鼠, 大鼠

宿主

  • 120
  • 64
  • 10
  • 8
  • 5
  • 2
  • 2
  • 2
  • 1

克隆类型

  • 137
  • 77
多克隆

标记

  • 118
  • 28
  • 17
  • 7
  • 6
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
This CCL2 antibody is un-conjugated

应用范围

  • 145
  • 69
  • 66
  • 32
  • 30
  • 25
  • 25
  • 18
  • 15
  • 14
  • 14
  • 13
  • 11
  • 11
  • 11
  • 6
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA
  • 抗原表位

    • 22
    • 15
    • 12
    • 12
    • 8
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 24-96

    原理

    Anti-CCL2 Antibody

    交叉反应 (详细)

    No cross-reactivity with other proteins.

    产品特性

    Anti-CCL2 Antibody (ABIN6719598). Tested in ELISA, WB applications. This antibody reacts with Mouse, Rat. This is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications.

    纯化方法

    Immunogen affinity purified.

    免疫原

    E. coli-derived rat CCL2 recombinant protein (Position: Q24-R96).

    亚型

    IgG
  • 应用备注

    Western blot, 0.1-0.5 μg/mL
    ELISA (Cap), 1-5 μg/mL

    说明

    Tested Species: In-house tested species with positive results. Other applications have not been tested. Optimal dilutions should be determined by end users.

    限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

    浓度

    500 μg/mL

    缓冲液

    Each vial contains 4 mg Trehalose, 0.9 mg NaCl and 0.2 mg Na2HPO4.

    储存条件

    4 °C,-20 °C

    储存方法

    Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
    It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles.
  • 抗原

    CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))

    别名

    Ccl2

    背景

    Synonyms: C-C motif chemokine 2, Immediate-early serum-responsive protein JE, Monocyte chemoattractant protein 1, Monocyte chemotactic protein 1, MCP-1, Small-inducible cytokine A2, Ccl2, Je, Mcp1, Scya2

    Tissue Specificity: Detected in various tissues including thymus, liver, lung, heart, and adult ovary.

    Background: Monocyte chemoattractant protein-1 (MCP-1), a member of the chemokine (chemotactic cytokine) family, is a potent monocyte agonist that is upregulated by oxidized lipids. MCP-1 is also known as CCL2, SCYA2, MCAF. MCAF is a member of family of factors involved in immune and inflammatory responses. The amino acid sequence deduced from the nucleotide sequence reveals the primary structure of the MCAF precursor to be composed of a putative signal peptide sequence of 23 amino acid residues and a mature MCAF sequence of 76 amino acid residues. MCP-1 plays a unique and crucial role in the initiation of atherosclerosis and may provide a new therapeutic target in this disorder. Human MCP-1 is a 8.7KDa non-glycoprotein, consisting of 99 amino acids in precursor form and 76 amino acids in mature form.

    分子量

    11 kDa

    基因ID

    24770

    UniProt

    P14844

    途径

    Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, ER-Nucleus Signaling, Unfolded Protein Response, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
You are here: